Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
Trial details
- Registry ID
- NCT05065216
- Phase
- Phase 2, Phase 3
Drug identity checked against registry records
Also recorded as DM199
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)NCT05065216 | DMAC | Phase 2, Phase 3 | Recruiting | 2026-12Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |